Cite
Ribeiro LNM, de Paula E, Rossi DA, et al. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains. Pharmaceutics. 2020;12(8)doi: 10.3390/pharmaceutics12080769.
Ribeiro, L. N. M., de Paula, E., Rossi, D. A., Monteiro, G. P., Júnior, E. C. V., Silva, R. R., Franco, R. R., Espíndola, F. S., Goulart, L. R., & Fonseca, B. B. (2020). Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains. Pharmaceutics, 12(8), . https://doi.org/10.3390/pharmaceutics12080769
Ribeiro, Lígia Nunes de Morais, et al. "Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains." Pharmaceutics vol. 12,8 (2020). doi: https://doi.org/10.3390/pharmaceutics12080769
Ribeiro LNM, de Paula E, Rossi DA, Monteiro GP, Júnior ECV, Silva RR, Franco RR, Espíndola FS, Goulart LR, Fonseca BB. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains. Pharmaceutics. 2020 Aug 14;12(8). doi: 10.3390/pharmaceutics12080769. PMID: 32823823; PMCID: PMC7465986.
Copy
Download .nbib